AngioDynamics Inc.
11/15/2024 | Press release | Distributed by Public on 11/15/2024 15:06
Proxy Results Form 8 K
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
|
(e)
|
As described below, the shareholders of AngioDynamics, Inc. ("AngioDynamics") voted on November 12, 2024 to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan (the "2020 Plan") to increase the number of shares available for issuance. The material terms of the 2020 Plan are described in Proposal 4 included in AngioDynamics' definitive proxy statement filed with the Securities and Exchange Commission on September 26, 2024, which description does not purport to be complete and is qualified in its entirety by reference to the full text of the 2020 Plan, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
|